Erratum: Author correction to "The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery" [Acta Pharm Sin B 12 (2022) 1460-1472].
Saved in:
| Title: | Erratum: Author correction to "The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery" [Acta Pharm Sin B 12 (2022) 1460-1472]. |
|---|---|
| Authors: | Li J; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Zhang Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Yu M; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Wang A; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Qiu Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China., Fan W; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China., Hovgaard L; Oral Formulation Development, Novo Nordisk A/S, Maalov 2760, Denmark., Yang M; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2100, Denmark., Li Y; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China., Wang R; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China., Li X; University of Texas at Dallas, Richardson, TX 75080, USA., Gan Y; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.; University of Chinese Academy of Sciences, Beijing 100049, China.; NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, National Institutes for Food and Drug Control, Beijing 100050, China. |
| Source: | Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2025 Jun; Vol. 15 (6), pp. 3353. Date of Electronic Publication: 2025 Apr 16. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2211-3835 (Print) Linking ISSN: 22113835 NLM ISO Abbreviation: Acta Pharm Sin B Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
